Micron Reaches New Milestone Dicks Earnings and Paxton Triumphs Over Cornyn Morning Market Overview Building an Income Portfolio to Match Social Security Benefits Russian Equities End Lower MOEX Russia Index Holds Near Flat Government to Sell Up to 2 Stake in Coal India Amid Falling Profits Amazon Reports Record Thanksgiving Holiday Sales and Item Volume SP 500 Futures Edge Higher Index on Track for Best Weekly Performance Since 2023 USIran Talks in Focus ASH Q1 2026 Earnings EPS Misses Estimates Slightly Shares Edge Lower Fair Isaac Corporation FICO Q1 2026 Earnings EPS Surges Past Estimates on Strong Analytics Demand FIX Q1 2026 Earnings Massive EPS Beat Drives Strong Performance Despite Revenue Data Gap CYTK Q1 2026 Earnings Narrower Loss Boosts Investor Confidence but Stock Falters PCG Q1 2026 Earnings Earnings Beat Expectations on Solid Operational Performance ADCT Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Surges Brookfield Corporation BN Holds Steady Near 46 as Markets Look for Direction Arena Group Holdings AREN Shares Edge Higher as Support Level Holds American Outdoor Brands AOUT Slides 125 as Stock Tests Key Support Levels Immuron IMRN Slips 1 as Stock Tests Key Support at 094 Blackstone Secured Lending Fund BXSL Edges Lower as Support Levels Come Into Focus Indias Gherkin Exports Reach Record 307 Million in FY26 Despite US Tariffs Assured Guaranty Ltd AGO Q1 2026 Earnings Strong EPS Surprise of 478 Driven by Favorable Loss Development T3 Defense Inc DFNS Surges Over 18 as Defense Sector Momentum Builds STGW Q1 2026 Earnings Narrow Earnings Miss Amid Solid Execution CEPU Q4 2024 Earnings Steep EPS Miss Pressures Shares as Argentine Headwinds Intensify MVB Financial Corp Q1 2026 Earnings Earnings Beat Expectations Amidst Modest Revenue Headwinds EXPE Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Resilient Travel Demand Vontier Corporation VNT Q1 2026 Earnings EPS Slightly Below Estimate Stock Gains Amid Broader Sentiment Lite Strategy Inc LITS Q4 2024 Earnings Significant EPS Miss Amid Strategic Challenges CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline